Roland Douglas Shytle

This inventor holds 17 USPTO granted patents and 7 published patent applications and 2 EPO patents. Top assignees: University of South Florida, Natura Therapeutics, Inc., Targacept, Inc.. Active years: 2000-2025.

USPTO Granted Patents = 17 (Patent Applications = 7)

% Patents Active = 70.6

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 83(Granted Patents)

Location History:

Lutz, FL (US) (2000 - 2005)
Largo, FL (US) (2014 - 2022)

Company Filing History:

15 out of 1,985

University of South Florida

patents

2 out of 3

Natura Therapeutics, Inc.

The United States Government as Represented by the Department of Veterans Affairs

patents

5. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2025

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12286445 - Organic anion lithium ionic cocrystal compounds and compositions (2025-04-29),

2. 11459341 - Organic anion lithium ionic cocrystal compounds and compositions (2022-10-04),

3. 10870665 - Organic anion lithium ionic cocrystal compounds and compositions (2020-12-22),

4. 10842797 - Nutraceutical co-crystal compositions (2020-11-24),

5. 10828312 - Lithium cholesterol compositions, including, but not limited to lithium cholesterol sulfate compositions, and methods of treatment for Alzheimer's disease and neurological disorders (2020-11-10),

6. 10435416 - Organic anion lithium ionic cocrystal compounds and compositions (2019-10-08),

7. 10376521 - Nutraceutical co-crystal compositions (2019-08-13),

8. 10130708 - Lithium cocrystal compositions (2018-11-20),

9. 10098909 - Ionic cocrystal of lithium, lispro, for the treatment of fragile X syndrome (2018-10-16),

10. 9840521 - Organic anion lithium ionic cocrystal compounds and compositions (2017-12-12),

11. 9827285 - Compositions and methods of improving cognitive performance (2017-11-28),

12. 9603869 - Lithium co-crystals and an additional neuropsychiatric agent for treatment of neuropsychiatric disorders (2017-03-28),

13. 9180191 - Treatment of suicidal ideation or behavior using inhibitors of nicotinic acetylcholine receptors (2015-11-10),

14. 8906414 - Methods and compositions for improving bioavailability of epigallocatechin gallate (EGCG) (2014-12-09),

15. 8778894 - Luteolin and diosmin/diosmetin as novel STAT3 inhibitors for treating autism (2014-07-15),

Title: The Innovative Contributions of Roland Douglas Shytle

Introduction

Roland Douglas Shytle is a notable inventor based in Largo, FL (US), recognized for his significant contributions to the field of pharmaceutical compositions. With a total of 17 patents to his name, Shytle has made remarkable advancements in the development of organic anion lithium ionic cocrystal compounds.

Latest Patents

Among his latest patents, Shytle has developed organic anion lithium ionic cocrystal compounds and compositions. These cocrystals have the formula LiX·aM, or a solvate or hydrate thereof, where X represents a conjugate base of an organic acid, M is a neutral organic molecule, and a ranges from 0.5 to 4. His work includes pharmaceutical compositions comprising such cocrystals, cocrystal solvates, or cocrystal hydrates, along with methods for preparing these innovative compounds.

Career Highlights

Shytle has had a distinguished career, working with esteemed institutions such as the University of South Florida and Natura Therapeutics, Inc. His research and inventions have contributed significantly to advancements in pharmaceutical sciences.

Collaborations

Shytle has collaborated with notable individuals in his field, including Adam John Smith and Jun Tan. These partnerships have further enhanced his innovative work and contributions to the industry.

Conclusion

Roland Douglas Shytle's inventive spirit and dedication to research have led to significant advancements in pharmaceutical compositions, particularly in the realm of organic anion lithium ionic cocrystal compounds. His contributions continue to impact the field positively.